Capricor Therapeutics (CAPR) - Stock price history

Stock price history of Capricor Therapeutics from 2007 to 2026

Annual Stock Price Performance

Year	Performance
2026	-70.89%
2025	92.91%
2024	169.53%
2023	27.01%
2022	21.38%
2021	-21.66%
2020	178.86%
2019	-74.40%
2018	-73.89%
2017	-38.04%
2016	-9.52%
2015	-18.13%
2014	10.29%
2013	62.50%
2012	-90.91%
2011	-5.17%
2010	-48.76%
2009	51.25%
2008	-84.55%
2007	511.11%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Johnson & Johnson JNJ	A$394.78	3.96%	🇺🇸 USA
Neurocrine Biosciences NBIX	A$237.77	1.10%	🇺🇸 USA
Cytokinetics CYTK	A$90.76	2.09%	🇺🇸 USA
Celldex Therapeutics CLDX	A$42.13	-0.61%	🇺🇸 USA
Palatin Technologies PTN	A$7.71	3.54%	🇺🇸 USA
Eterna Therapeutics ERNA	A$2.78	-3.40%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Capricor Therapeutics (CAPR)